1-2 of 2
Andreas Grüneisen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Myelodysplastic Syndrome Treated with Intensive Chemotherapy within the AMLCG99 Trial

Utz Krug, MD, Carsten Muller-Tidow, MD, Matthias Stelljes, Maria Cristina Sauerland, MSc, Achim Heinecke, Ph.D., Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Jan Braess, MD, Karsten Spiekermann, MD, Sarah Volpert, PhD, Peter Staib, Andreas Grüneisen, MD, Wolfgang Kern, MD, Albrecht Reichle, MD, Wolf-Dieter Ludwig, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Carlo Aul, MD, Herbert Rasche, MD, Eva Lengfelder, MD, Eckhard Thiel, Joachim Kienast, Hubert Serve, MD, Bernhard Josef Woermann, MD, Wolfgang Hiddemann, MD, Wolfgang E. Berdel, Thomas Buchner, MD
Journal: Blood
Blood (2011) 118 (21): 2773.
https://doi.org/10.1182/blood.V118.21.2773.2773
Published: 2011
Journal Articles

BCR-ABL P-Loop Deletion Detected in Imatinib-Resistant CML Patients Corresponds to Splice Variant Associated with L248V Point Mutation, Retains BCR-ABL Kinase Activity, and Responds to Dasatinib Treatment.

Nikolas von Bubnoff, MD, Philipp Erben, MD, Martin Müller, MD, Tanja Lahaye, MD, Susanne Schnittger, MD, Frank Schlegel, MD, Hubert Serve, MD, Andreas Grüneisen, MD, Rudiger Hehlmann, MD, Christian Peschel, MD, Justus Duyster, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2006) 108 (11): 2168.
https://doi.org/10.1182/blood.V108.11.2168.2168
Published: 2006